nodes	percent_of_prediction	percent_of_DWPC	metapath
Leucovorin—ABCC3—Etoposide—uterine cancer	0.24	0.335	CbGbCtD
Leucovorin—ABCC3—Doxorubicin—uterine cancer	0.164	0.228	CbGbCtD
Leucovorin—ABCC2—Carboplatin—uterine cancer	0.13	0.181	CbGbCtD
Leucovorin—ABCC2—Etoposide—uterine cancer	0.109	0.152	CbGbCtD
Leucovorin—ABCC2—Doxorubicin—uterine cancer	0.0745	0.104	CbGbCtD
Leucovorin—TYMS—G1/S-Specific Transcription—RRM2—uterine cancer	0.0035	0.0636	CbGpPWpGaD
Leucovorin—TYMS—Podofilox—Etoposide—uterine cancer	0.00275	0.531	CbGdCrCtD
Leucovorin—TYMS—uterine cervix—uterine cancer	0.0025	0.0756	CbGeAlD
Leucovorin—TYMS—smooth muscle tissue—uterine cancer	0.00243	0.0734	CbGeAlD
Leucovorin—ABCC3—ABC-family proteins mediated transport—ABCC9—uterine cancer	0.00243	0.0441	CbGpPWpGaD
Leucovorin—ABCC4—ABC-family proteins mediated transport—ABCC9—uterine cancer	0.00228	0.0415	CbGpPWpGaD
Leucovorin—TYMS—endometrium—uterine cancer	0.00227	0.0684	CbGeAlD
Leucovorin—Folic Acid—MTHFR—uterine cancer	0.00226	0.373	CrCbGaD
Leucovorin—Tetrahydrofolic acid—MTHFR—uterine cancer	0.00226	0.373	CrCbGaD
Leucovorin—TYMS—mammalian vulva—uterine cancer	0.00219	0.0661	CbGeAlD
Leucovorin—Extravasation—Dactinomycin—uterine cancer	0.00215	0.0117	CcSEcCtD
Leucovorin—Sensitisation—Epirubicin—uterine cancer	0.00213	0.0116	CcSEcCtD
Leucovorin—TYMS—E2F mediated regulation of DNA replication—RRM2—uterine cancer	0.00206	0.0374	CbGpPWpGaD
Leucovorin—TYMS—Fluoropyrimidine Activity—RRM2—uterine cancer	0.00206	0.0374	CbGpPWpGaD
Leucovorin—Anaphylactoid reaction—Progesterone—uterine cancer	0.00199	0.0109	CcSEcCtD
Leucovorin—Sensitisation—Doxorubicin—uterine cancer	0.00197	0.0108	CcSEcCtD
Leucovorin—ABCC3—decidua—uterine cancer	0.00196	0.0591	CbGeAlD
Leucovorin—ABCC2—ABC-family proteins mediated transport—ABCC9—uterine cancer	0.00193	0.035	CbGpPWpGaD
Leucovorin—ABCC3—renal system—uterine cancer	0.00192	0.058	CbGeAlD
Leucovorin—TYMS—female reproductive system—uterine cancer	0.00188	0.0566	CbGeAlD
Leucovorin—Anaphylactoid reaction—Medroxyprogesterone Acetate—uterine cancer	0.0018	0.00985	CcSEcCtD
Leucovorin—Infection—Carboplatin—uterine cancer	0.00179	0.00978	CcSEcCtD
Leucovorin—ABCC3—Bile acid and bile salt metabolism—AKR1C1—uterine cancer	0.00178	0.0324	CbGpPWpGaD
Leucovorin—TYMS—female gonad—uterine cancer	0.00171	0.0515	CbGeAlD
Leucovorin—ABCC3—Fluoropyrimidine Activity—RRM2—uterine cancer	0.0017	0.031	CbGpPWpGaD
Leucovorin—TYMS—vagina—uterine cancer	0.0017	0.0512	CbGeAlD
Leucovorin—Rigors—Etoposide—uterine cancer	0.00166	0.00908	CcSEcCtD
Leucovorin—Blood creatinine increased—Medroxyprogesterone Acetate—uterine cancer	0.00163	0.00893	CcSEcCtD
Leucovorin—ABCC4—Fluoropyrimidine Activity—RRM2—uterine cancer	0.0016	0.0291	CbGpPWpGaD
Leucovorin—ABCC4—renal system—uterine cancer	0.00159	0.0479	CbGeAlD
Leucovorin—Kidney function abnormal—Epirubicin—uterine cancer	0.00157	0.0086	CcSEcCtD
Leucovorin—Extravasation—Etoposide—uterine cancer	0.00155	0.0085	CcSEcCtD
Leucovorin—Methotrexate—MTHFR—uterine cancer	0.00155	0.255	CrCbGaD
Leucovorin—ABCC3—female reproductive system—uterine cancer	0.00154	0.0464	CbGeAlD
Leucovorin—ABCC2—renal system—uterine cancer	0.00154	0.0463	CbGeAlD
Leucovorin—Kidney function abnormal—Doxorubicin—uterine cancer	0.00145	0.00796	CcSEcCtD
Leucovorin—Neuropathy peripheral—Progesterone—uterine cancer	0.00145	0.00795	CcSEcCtD
Leucovorin—Body temperature increased—Carboplatin—uterine cancer	0.00142	0.00778	CcSEcCtD
Leucovorin—TYMS—Danazol—Progesterone—uterine cancer	0.00142	0.273	CbGdCrCtD
Leucovorin—ABCC4—uterus—uterine cancer	0.00141	0.0426	CbGeAlD
Leucovorin—ABCC3—female gonad—uterine cancer	0.0014	0.0423	CbGeAlD
Leucovorin—Lethargy—Dactinomycin—uterine cancer	0.00139	0.00759	CcSEcCtD
Leucovorin—ABCC3—Bile acid and bile salt metabolism—AKR1C3—uterine cancer	0.00137	0.0249	CbGpPWpGaD
Leucovorin—Neuropathy peripheral—Medroxyprogesterone Acetate—uterine cancer	0.00132	0.0072	CcSEcCtD
Leucovorin—Stomatitis—Medroxyprogesterone Acetate—uterine cancer	0.00131	0.00716	CcSEcCtD
Leucovorin—Neuropathy—Etoposide—uterine cancer	0.00127	0.00696	CcSEcCtD
Leucovorin—ABCC4—female reproductive system—uterine cancer	0.00127	0.0383	CbGeAlD
Leucovorin—Febrile neutropenia—Epirubicin—uterine cancer	0.00126	0.00691	CcSEcCtD
Leucovorin—Serum creatinine increased—Epirubicin—uterine cancer	0.00123	0.00676	CcSEcCtD
Leucovorin—ABCC2—female reproductive system—uterine cancer	0.00123	0.0371	CbGeAlD
Leucovorin—TYMS—One Carbon Metabolism—MTHFR—uterine cancer	0.00119	0.0216	CbGpPWpGaD
Leucovorin—Alopecia—Progesterone—uterine cancer	0.00118	0.00643	CcSEcCtD
Leucovorin—Febrile neutropenia—Doxorubicin—uterine cancer	0.00117	0.00639	CcSEcCtD
Leucovorin—Erythema—Progesterone—uterine cancer	0.00116	0.00634	CcSEcCtD
Leucovorin—ABCC4—female gonad—uterine cancer	0.00116	0.0349	CbGeAlD
Leucovorin—TYMS—Retinoblastoma (RB) in Cancer—MSH6—uterine cancer	0.00115	0.0209	CbGpPWpGaD
Leucovorin—Serum creatinine increased—Doxorubicin—uterine cancer	0.00114	0.00625	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—MAP3K4—uterine cancer	0.00113	0.0205	CbGpPWpGaD
Leucovorin—TYMS—lymph node—uterine cancer	0.0011	0.0331	CbGeAlD
Leucovorin—TYMS—E2F transcription factor network—RRM2—uterine cancer	0.00109	0.0198	CbGpPWpGaD
Leucovorin—Chills—Medroxyprogesterone Acetate—uterine cancer	0.00108	0.00592	CcSEcCtD
Leucovorin—Ill-defined disorder—Progesterone—uterine cancer	0.00107	0.00588	CcSEcCtD
Leucovorin—TYMS—Trans-sulfuration and one carbon metabolism—MTHFR—uterine cancer	0.00107	0.0194	CbGpPWpGaD
Leucovorin—Alopecia—Medroxyprogesterone Acetate—uterine cancer	0.00107	0.00583	CcSEcCtD
Leucovorin—Erythema—Medroxyprogesterone Acetate—uterine cancer	0.00105	0.00574	CcSEcCtD
Leucovorin—Malaise—Progesterone—uterine cancer	0.00104	0.00571	CcSEcCtD
Leucovorin—TYMS—Fluoropyrimidine Activity—MTHFR—uterine cancer	0.00104	0.0189	CbGpPWpGaD
Leucovorin—Syncope—Progesterone—uterine cancer	0.00104	0.00568	CcSEcCtD
Leucovorin—TYMS—Nucleotide metabolism—RRM2—uterine cancer	0.00103	0.0188	CbGpPWpGaD
Leucovorin—Dysgeusia—Medroxyprogesterone Acetate—uterine cancer	0.00103	0.00562	CcSEcCtD
Leucovorin—Stomatitis—Dactinomycin—uterine cancer	0.00102	0.00559	CcSEcCtD
Leucovorin—Loss of consciousness—Progesterone—uterine cancer	0.00102	0.00557	CcSEcCtD
Leucovorin—Anaphylactoid reaction—Etoposide—uterine cancer	0.00102	0.00556	CcSEcCtD
Leucovorin—TYMS—Levonorgestrel—Progesterone—uterine cancer	0.00102	0.196	CbGdCrCtD
Leucovorin—Convulsion—Progesterone—uterine cancer	0.001	0.00549	CcSEcCtD
Leucovorin—Discomfort—Progesterone—uterine cancer	0.000974	0.00533	CcSEcCtD
Leucovorin—Ill-defined disorder—Medroxyprogesterone Acetate—uterine cancer	0.000974	0.00533	CcSEcCtD
Leucovorin—Confusional state—Progesterone—uterine cancer	0.000953	0.00522	CcSEcCtD
Leucovorin—TYMS—Retinoblastoma (RB) in Cancer—RRM2—uterine cancer	0.000947	0.0172	CbGpPWpGaD
Leucovorin—Malaise—Medroxyprogesterone Acetate—uterine cancer	0.000946	0.00518	CcSEcCtD
Leucovorin—Anaphylactic shock—Progesterone—uterine cancer	0.000945	0.00517	CcSEcCtD
Leucovorin—Syncope—Medroxyprogesterone Acetate—uterine cancer	0.000941	0.00515	CcSEcCtD
Leucovorin—Infection—Progesterone—uterine cancer	0.000939	0.00514	CcSEcCtD
Leucovorin—Rigors—Epirubicin—uterine cancer	0.00093	0.00509	CcSEcCtD
Leucovorin—Shock—Progesterone—uterine cancer	0.00093	0.00509	CcSEcCtD
Leucovorin—Loss of consciousness—Medroxyprogesterone Acetate—uterine cancer	0.000922	0.00505	CcSEcCtD
Leucovorin—Skin disorder—Progesterone—uterine cancer	0.000918	0.00502	CcSEcCtD
Leucovorin—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.000909	0.00498	CcSEcCtD
Leucovorin—Anorexia—Progesterone—uterine cancer	0.000901	0.00493	CcSEcCtD
Leucovorin—ABCC3—lymph node—uterine cancer	0.0009	0.0272	CbGeAlD
Leucovorin—Discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000883	0.00483	CcSEcCtD
Leucovorin—Extravasation—Epirubicin—uterine cancer	0.000871	0.00476	CcSEcCtD
Leucovorin—Confusional state—Medroxyprogesterone Acetate—uterine cancer	0.000863	0.00473	CcSEcCtD
Leucovorin—ABCC3—Fluoropyrimidine Activity—MTHFR—uterine cancer	0.000861	0.0157	CbGpPWpGaD
Leucovorin—Rigors—Doxorubicin—uterine cancer	0.000861	0.00471	CcSEcCtD
Leucovorin—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.000856	0.00469	CcSEcCtD
Leucovorin—Infection—Medroxyprogesterone Acetate—uterine cancer	0.000851	0.00466	CcSEcCtD
Leucovorin—Chills—Dactinomycin—uterine cancer	0.000844	0.00462	CcSEcCtD
Leucovorin—Dyspnoea—Progesterone—uterine cancer	0.000842	0.00461	CcSEcCtD
Leucovorin—Shock—Medroxyprogesterone Acetate—uterine cancer	0.000842	0.00461	CcSEcCtD
Leucovorin—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.000838	0.00459	CcSEcCtD
Leucovorin—Dyspepsia—Progesterone—uterine cancer	0.000832	0.00455	CcSEcCtD
Leucovorin—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.000832	0.00455	CcSEcCtD
Leucovorin—Alopecia—Dactinomycin—uterine cancer	0.000831	0.00455	CcSEcCtD
Leucovorin—Decreased appetite—Progesterone—uterine cancer	0.000821	0.0045	CcSEcCtD
Leucovorin—Erythema—Dactinomycin—uterine cancer	0.000818	0.00448	CcSEcCtD
Leucovorin—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.000816	0.00447	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Progesterone—uterine cancer	0.000816	0.00447	CcSEcCtD
Leucovorin—Fatigue—Progesterone—uterine cancer	0.000815	0.00446	CcSEcCtD
Leucovorin—ABCC4—Fluoropyrimidine Activity—MTHFR—uterine cancer	0.00081	0.0147	CbGpPWpGaD
Leucovorin—Constipation—Progesterone—uterine cancer	0.000808	0.00442	CcSEcCtD
Leucovorin—Extravasation—Doxorubicin—uterine cancer	0.000805	0.00441	CcSEcCtD
Leucovorin—TYMS—G1/S Transition—RRM2—uterine cancer	0.000791	0.0144	CbGpPWpGaD
Leucovorin—Feeling abnormal—Progesterone—uterine cancer	0.000779	0.00426	CcSEcCtD
Leucovorin—Gastrointestinal pain—Progesterone—uterine cancer	0.000773	0.00423	CcSEcCtD
Leucovorin—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.000763	0.00418	CcSEcCtD
Leucovorin—Ill-defined disorder—Dactinomycin—uterine cancer	0.000759	0.00416	CcSEcCtD
Leucovorin—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.000754	0.00413	CcSEcCtD
Leucovorin—Urticaria—Progesterone—uterine cancer	0.000751	0.00411	CcSEcCtD
Leucovorin—Body temperature increased—Progesterone—uterine cancer	0.000747	0.00409	CcSEcCtD
Leucovorin—Abdominal pain—Progesterone—uterine cancer	0.000747	0.00409	CcSEcCtD
Leucovorin—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.000744	0.00407	CcSEcCtD
Leucovorin—ABCC4—lymph node—uterine cancer	0.000743	0.0224	CbGeAlD
Leucovorin—Neuropathy peripheral—Etoposide—uterine cancer	0.000743	0.00407	CcSEcCtD
Leucovorin—TYMS—Circadian rythm related genes—STAR—uterine cancer	0.000741	0.0135	CbGpPWpGaD
Leucovorin—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.000739	0.00405	CcSEcCtD
Leucovorin—Stomatitis—Etoposide—uterine cancer	0.000739	0.00404	CcSEcCtD
Leucovorin—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.000738	0.00404	CcSEcCtD
Leucovorin—Malaise—Dactinomycin—uterine cancer	0.000738	0.00404	CcSEcCtD
Leucovorin—Leukopenia—Dactinomycin—uterine cancer	0.000733	0.00401	CcSEcCtD
Leucovorin—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.000732	0.00401	CcSEcCtD
Leucovorin—ABCC2—lymph node—uterine cancer	0.000719	0.0217	CbGeAlD
Leucovorin—Neuropathy—Epirubicin—uterine cancer	0.000713	0.0039	CcSEcCtD
Leucovorin—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000706	0.00386	CcSEcCtD
Leucovorin—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.0007	0.00383	CcSEcCtD
Leucovorin—Hypersensitivity—Progesterone—uterine cancer	0.000696	0.00381	CcSEcCtD
Leucovorin—Discomfort—Dactinomycin—uterine cancer	0.000688	0.00377	CcSEcCtD
Leucovorin—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00068	0.00372	CcSEcCtD
Leucovorin—Asthenia—Progesterone—uterine cancer	0.000678	0.00371	CcSEcCtD
Leucovorin—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000677	0.0037	CcSEcCtD
Leucovorin—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000677	0.0037	CcSEcCtD
Leucovorin—Pruritus—Progesterone—uterine cancer	0.000669	0.00366	CcSEcCtD
Leucovorin—TYMS—Mitotic G1-G1/S phases—RRM2—uterine cancer	0.000667	0.0121	CbGpPWpGaD
Leucovorin—Infection—Dactinomycin—uterine cancer	0.000664	0.00363	CcSEcCtD
Leucovorin—Neuropathy—Doxorubicin—uterine cancer	0.00066	0.00361	CcSEcCtD
Leucovorin—Thrombocytopenia—Dactinomycin—uterine cancer	0.000654	0.00358	CcSEcCtD
Leucovorin—Diarrhoea—Progesterone—uterine cancer	0.000647	0.00354	CcSEcCtD
Leucovorin—Anorexia—Dactinomycin—uterine cancer	0.000637	0.00348	CcSEcCtD
Leucovorin—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000631	0.00345	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—INHBA—uterine cancer	0.000629	0.0114	CbGpPWpGaD
Leucovorin—Dizziness—Progesterone—uterine cancer	0.000625	0.00342	CcSEcCtD
Leucovorin—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000614	0.00336	CcSEcCtD
Leucovorin—Chills—Etoposide—uterine cancer	0.000611	0.00334	CcSEcCtD
Leucovorin—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000606	0.00332	CcSEcCtD
Leucovorin—TYMS—Circadian rythm related genes—HNF1B—uterine cancer	0.000604	0.011	CbGpPWpGaD
Leucovorin—Alopecia—Etoposide—uterine cancer	0.000601	0.00329	CcSEcCtD
Leucovorin—Vomiting—Progesterone—uterine cancer	0.000601	0.00329	CcSEcCtD
Leucovorin—Renal failure acute—Epirubicin—uterine cancer	0.000597	0.00327	CcSEcCtD
Leucovorin—Rash—Progesterone—uterine cancer	0.000596	0.00326	CcSEcCtD
Leucovorin—Dermatitis—Progesterone—uterine cancer	0.000595	0.00326	CcSEcCtD
Leucovorin—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000586	0.00321	CcSEcCtD
Leucovorin—Decreased appetite—Dactinomycin—uterine cancer	0.000581	0.00318	CcSEcCtD
Leucovorin—Dysgeusia—Etoposide—uterine cancer	0.00058	0.00317	CcSEcCtD
Leucovorin—Renal impairment—Epirubicin—uterine cancer	0.000579	0.00317	CcSEcCtD
Leucovorin—Fatigue—Dactinomycin—uterine cancer	0.000576	0.00315	CcSEcCtD
Leucovorin—Anaphylactoid reaction—Epirubicin—uterine cancer	0.00057	0.00312	CcSEcCtD
Leucovorin—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000566	0.0031	CcSEcCtD
Leucovorin—Lethargy—Epirubicin—uterine cancer	0.000563	0.00308	CcSEcCtD
Leucovorin—Nausea—Progesterone—uterine cancer	0.000561	0.00307	CcSEcCtD
Leucovorin—Renal failure acute—Doxorubicin—uterine cancer	0.000553	0.00302	CcSEcCtD
Leucovorin—Feeling abnormal—Dactinomycin—uterine cancer	0.00055	0.00301	CcSEcCtD
Leucovorin—Ill-defined disorder—Etoposide—uterine cancer	0.00055	0.00301	CcSEcCtD
Leucovorin—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000546	0.00299	CcSEcCtD
Leucovorin—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000544	0.00298	CcSEcCtD
Leucovorin—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00054	0.00296	CcSEcCtD
Leucovorin—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000539	0.00295	CcSEcCtD
Leucovorin—Renal impairment—Doxorubicin—uterine cancer	0.000536	0.00293	CcSEcCtD
Leucovorin—ABCC3—NRF2 pathway—NFE2L2—uterine cancer	0.000535	0.00973	CbGpPWpGaD
Leucovorin—Malaise—Etoposide—uterine cancer	0.000534	0.00292	CcSEcCtD
Leucovorin—Leukopenia—Etoposide—uterine cancer	0.00053	0.0029	CcSEcCtD
Leucovorin—Body temperature increased—Dactinomycin—uterine cancer	0.000528	0.00289	CcSEcCtD
Leucovorin—Abdominal pain—Dactinomycin—uterine cancer	0.000528	0.00289	CcSEcCtD
Leucovorin—Anaphylactoid reaction—Doxorubicin—uterine cancer	0.000527	0.00288	CcSEcCtD
Leucovorin—Loss of consciousness—Etoposide—uterine cancer	0.000521	0.00285	CcSEcCtD
Leucovorin—Lethargy—Doxorubicin—uterine cancer	0.000521	0.00285	CcSEcCtD
Leucovorin—Blood creatinine increased—Epirubicin—uterine cancer	0.000517	0.00283	CcSEcCtD
Leucovorin—Convulsion—Etoposide—uterine cancer	0.000513	0.00281	CcSEcCtD
Leucovorin—ABCC3—NRF2 pathway—GPX3—uterine cancer	0.000511	0.00928	CbGpPWpGaD
Leucovorin—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000509	0.00278	CcSEcCtD
Leucovorin—Abdominal pain upper—Epirubicin—uterine cancer	0.000504	0.00276	CcSEcCtD
Leucovorin—ABCC4—NRF2 pathway—NFE2L2—uterine cancer	0.000503	0.00915	CbGpPWpGaD
Leucovorin—Discomfort—Etoposide—uterine cancer	0.000498	0.00273	CcSEcCtD
Leucovorin—Hypersensitivity—Dactinomycin—uterine cancer	0.000492	0.00269	CcSEcCtD
Leucovorin—Confusional state—Etoposide—uterine cancer	0.000487	0.00267	CcSEcCtD
Leucovorin—Anaphylactic shock—Etoposide—uterine cancer	0.000483	0.00265	CcSEcCtD
Leucovorin—Infection—Etoposide—uterine cancer	0.00048	0.00263	CcSEcCtD
Leucovorin—ABCC4—NRF2 pathway—GPX3—uterine cancer	0.00048	0.00872	CbGpPWpGaD
Leucovorin—Asthenia—Dactinomycin—uterine cancer	0.000479	0.00262	CcSEcCtD
Leucovorin—Blood creatinine increased—Doxorubicin—uterine cancer	0.000478	0.00262	CcSEcCtD
Leucovorin—Thrombocytopenia—Etoposide—uterine cancer	0.000473	0.00259	CcSEcCtD
Leucovorin—Skin disorder—Etoposide—uterine cancer	0.00047	0.00257	CcSEcCtD
Leucovorin—Abdominal pain upper—Doxorubicin—uterine cancer	0.000466	0.00255	CcSEcCtD
Leucovorin—Anorexia—Etoposide—uterine cancer	0.000461	0.00252	CcSEcCtD
Leucovorin—Diarrhoea—Dactinomycin—uterine cancer	0.000457	0.0025	CcSEcCtD
Leucovorin—TYMS—Cell Cycle—MLH3—uterine cancer	0.000441	0.00802	CbGpPWpGaD
Leucovorin—Dyspnoea—Etoposide—uterine cancer	0.000431	0.00236	CcSEcCtD
Leucovorin—Vomiting—Dactinomycin—uterine cancer	0.000425	0.00232	CcSEcCtD
Leucovorin—ABCC2—NRF2 pathway—NFE2L2—uterine cancer	0.000424	0.00771	CbGpPWpGaD
Leucovorin—Rash—Dactinomycin—uterine cancer	0.000421	0.0023	CcSEcCtD
Leucovorin—Decreased appetite—Etoposide—uterine cancer	0.00042	0.0023	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Etoposide—uterine cancer	0.000417	0.00228	CcSEcCtD
Leucovorin—Fatigue—Etoposide—uterine cancer	0.000417	0.00228	CcSEcCtD
Leucovorin—Neuropathy peripheral—Epirubicin—uterine cancer	0.000416	0.00228	CcSEcCtD
Leucovorin—Stomatitis—Epirubicin—uterine cancer	0.000414	0.00227	CcSEcCtD
Leucovorin—Constipation—Etoposide—uterine cancer	0.000413	0.00226	CcSEcCtD
Leucovorin—ABCC2—NRF2 pathway—GPX3—uterine cancer	0.000405	0.00736	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	0.000404	0.00734	CbGpPWpGaD
Leucovorin—TYMS—Mitotic G1-G1/S phases—CDKN2B—uterine cancer	0.000402	0.00731	CbGpPWpGaD
Leucovorin—Feeling abnormal—Etoposide—uterine cancer	0.000398	0.00218	CcSEcCtD
Leucovorin—Nausea—Dactinomycin—uterine cancer	0.000397	0.00217	CcSEcCtD
Leucovorin—Gastrointestinal pain—Etoposide—uterine cancer	0.000395	0.00216	CcSEcCtD
Leucovorin—TYMS—Fluoropyrimidine Activity—TP53—uterine cancer	0.000395	0.00718	CbGpPWpGaD
Leucovorin—TYMS—Circadian rythm related genes—EZH2—uterine cancer	0.000388	0.00705	CbGpPWpGaD
Leucovorin—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000385	0.00211	CcSEcCtD
Leucovorin—Urticaria—Etoposide—uterine cancer	0.000384	0.0021	CcSEcCtD
Leucovorin—Stomatitis—Doxorubicin—uterine cancer	0.000383	0.0021	CcSEcCtD
Leucovorin—Body temperature increased—Etoposide—uterine cancer	0.000382	0.00209	CcSEcCtD
Leucovorin—Abdominal pain—Etoposide—uterine cancer	0.000382	0.00209	CcSEcCtD
Leucovorin—TYMS—E2F transcription factor network—CDKN2A—uterine cancer	0.000376	0.00684	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	0.000374	0.0068	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.000369	0.00671	CbGpPWpGaD
Leucovorin—Hypersensitivity—Etoposide—uterine cancer	0.000356	0.00195	CcSEcCtD
Leucovorin—Asthenia—Etoposide—uterine cancer	0.000347	0.0019	CcSEcCtD
Leucovorin—TYMS—Cell Cycle, Mitotic—NDC80—uterine cancer	0.000345	0.00627	CbGpPWpGaD
Leucovorin—Chills—Epirubicin—uterine cancer	0.000342	0.00187	CcSEcCtD
Leucovorin—Pruritus—Etoposide—uterine cancer	0.000342	0.00187	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	0.00034	0.00618	CbGpPWpGaD
Leucovorin—Alopecia—Epirubicin—uterine cancer	0.000337	0.00184	CcSEcCtD
Leucovorin—TYMS—E2F transcription factor network—CDKN1B—uterine cancer	0.000333	0.00605	CbGpPWpGaD
Leucovorin—Erythema—Epirubicin—uterine cancer	0.000332	0.00182	CcSEcCtD
Leucovorin—Diarrhoea—Etoposide—uterine cancer	0.000331	0.00181	CcSEcCtD
Leucovorin—ABCC3—Fluoropyrimidine Activity—TP53—uterine cancer	0.000327	0.00594	CbGpPWpGaD
Leucovorin—Dysgeusia—Epirubicin—uterine cancer	0.000325	0.00178	CcSEcCtD
Leucovorin—Dizziness—Etoposide—uterine cancer	0.00032	0.00175	CcSEcCtD
Leucovorin—Chills—Doxorubicin—uterine cancer	0.000317	0.00173	CcSEcCtD
Leucovorin—Alopecia—Doxorubicin—uterine cancer	0.000312	0.00171	CcSEcCtD
Leucovorin—TYMS—Cell Cycle—NDC80—uterine cancer	0.000308	0.00561	CbGpPWpGaD
Leucovorin—Ill-defined disorder—Epirubicin—uterine cancer	0.000308	0.00169	CcSEcCtD
Leucovorin—ABCC4—Fluoropyrimidine Activity—TP53—uterine cancer	0.000307	0.00559	CbGpPWpGaD
Leucovorin—Vomiting—Etoposide—uterine cancer	0.000307	0.00168	CcSEcCtD
Leucovorin—Erythema—Doxorubicin—uterine cancer	0.000307	0.00168	CcSEcCtD
Leucovorin—Rash—Etoposide—uterine cancer	0.000305	0.00167	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	0.000305	0.00554	CbGpPWpGaD
Leucovorin—Dermatitis—Etoposide—uterine cancer	0.000305	0.00167	CcSEcCtD
Leucovorin—Dysgeusia—Doxorubicin—uterine cancer	0.000301	0.00165	CcSEcCtD
Leucovorin—Malaise—Epirubicin—uterine cancer	0.000299	0.00164	CcSEcCtD
Leucovorin—Syncope—Epirubicin—uterine cancer	0.000298	0.00163	CcSEcCtD
Leucovorin—Leukopenia—Epirubicin—uterine cancer	0.000297	0.00163	CcSEcCtD
Leucovorin—TYMS—Cell Cycle, Mitotic—POLD1—uterine cancer	0.000293	0.00533	CbGpPWpGaD
Leucovorin—TYMS—E2F transcription factor network—EP300—uterine cancer	0.000292	0.00532	CbGpPWpGaD
Leucovorin—Loss of consciousness—Epirubicin—uterine cancer	0.000292	0.0016	CcSEcCtD
Leucovorin—TYMS—Retinoblastoma (RB) in Cancer—CDKN1B—uterine cancer	0.000289	0.00526	CbGpPWpGaD
Leucovorin—Convulsion—Epirubicin—uterine cancer	0.000288	0.00157	CcSEcCtD
Leucovorin—Nausea—Etoposide—uterine cancer	0.000287	0.00157	CcSEcCtD
Leucovorin—Ill-defined disorder—Doxorubicin—uterine cancer	0.000285	0.00156	CcSEcCtD
Leucovorin—Discomfort—Epirubicin—uterine cancer	0.000279	0.00153	CcSEcCtD
Leucovorin—Malaise—Doxorubicin—uterine cancer	0.000277	0.00152	CcSEcCtD
Leucovorin—Syncope—Doxorubicin—uterine cancer	0.000276	0.00151	CcSEcCtD
Leucovorin—Leukopenia—Doxorubicin—uterine cancer	0.000275	0.00151	CcSEcCtD
Leucovorin—Confusional state—Epirubicin—uterine cancer	0.000273	0.0015	CcSEcCtD
Leucovorin—Anaphylactic shock—Epirubicin—uterine cancer	0.000271	0.00148	CcSEcCtD
Leucovorin—Loss of consciousness—Doxorubicin—uterine cancer	0.00027	0.00148	CcSEcCtD
Leucovorin—Infection—Epirubicin—uterine cancer	0.000269	0.00147	CcSEcCtD
Leucovorin—ABCC4—Ectoderm Differentiation—FGFR2—uterine cancer	0.000268	0.00487	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.000267	0.00485	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.000267	0.00485	CbGpPWpGaD
Leucovorin—Shock—Epirubicin—uterine cancer	0.000267	0.00146	CcSEcCtD
Leucovorin—Convulsion—Doxorubicin—uterine cancer	0.000266	0.00146	CcSEcCtD
Leucovorin—Thrombocytopenia—Epirubicin—uterine cancer	0.000265	0.00145	CcSEcCtD
Leucovorin—Skin disorder—Epirubicin—uterine cancer	0.000263	0.00144	CcSEcCtD
Leucovorin—TYMS—Cell Cycle—POLD1—uterine cancer	0.000262	0.00477	CbGpPWpGaD
Leucovorin—Discomfort—Doxorubicin—uterine cancer	0.000258	0.00141	CcSEcCtD
Leucovorin—Anorexia—Epirubicin—uterine cancer	0.000258	0.00141	CcSEcCtD
Leucovorin—ABCC3—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000254	0.00461	CbGpPWpGaD
Leucovorin—Confusional state—Doxorubicin—uterine cancer	0.000253	0.00138	CcSEcCtD
Leucovorin—Anaphylactic shock—Doxorubicin—uterine cancer	0.000251	0.00137	CcSEcCtD
Leucovorin—Infection—Doxorubicin—uterine cancer	0.000249	0.00136	CcSEcCtD
Leucovorin—Shock—Doxorubicin—uterine cancer	0.000247	0.00135	CcSEcCtD
Leucovorin—Thrombocytopenia—Doxorubicin—uterine cancer	0.000245	0.00134	CcSEcCtD
Leucovorin—TYMS—Cell Cycle, Mitotic—RRM2—uterine cancer	0.000245	0.00444	CbGpPWpGaD
Leucovorin—Skin disorder—Doxorubicin—uterine cancer	0.000244	0.00133	CcSEcCtD
Leucovorin—TYMS—G1/S Transition—CDKN1B—uterine cancer	0.000242	0.00439	CbGpPWpGaD
Leucovorin—Dyspnoea—Epirubicin—uterine cancer	0.000242	0.00132	CcSEcCtD
Leucovorin—Anorexia—Doxorubicin—uterine cancer	0.000239	0.00131	CcSEcCtD
Leucovorin—ABCC4—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000239	0.00434	CbGpPWpGaD
Leucovorin—Dyspepsia—Epirubicin—uterine cancer	0.000239	0.00131	CcSEcCtD
Leucovorin—Decreased appetite—Epirubicin—uterine cancer	0.000236	0.00129	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000234	0.00128	CcSEcCtD
Leucovorin—Fatigue—Epirubicin—uterine cancer	0.000234	0.00128	CcSEcCtD
Leucovorin—Constipation—Epirubicin—uterine cancer	0.000232	0.00127	CcSEcCtD
Leucovorin—TYMS—Mitotic G1-G1/S phases—CDKN2A—uterine cancer	0.00023	0.00418	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	0.000227	0.00413	CbGpPWpGaD
Leucovorin—Dyspnoea—Doxorubicin—uterine cancer	0.000224	0.00122	CcSEcCtD
Leucovorin—Feeling abnormal—Epirubicin—uterine cancer	0.000223	0.00122	CcSEcCtD
Leucovorin—Gastrointestinal pain—Epirubicin—uterine cancer	0.000222	0.00121	CcSEcCtD
Leucovorin—Dyspepsia—Doxorubicin—uterine cancer	0.000221	0.00121	CcSEcCtD
Leucovorin—TYMS—Cell Cycle—RRM2—uterine cancer	0.000219	0.00397	CbGpPWpGaD
Leucovorin—Decreased appetite—Doxorubicin—uterine cancer	0.000218	0.00119	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000216	0.00118	CcSEcCtD
Leucovorin—Fatigue—Doxorubicin—uterine cancer	0.000216	0.00118	CcSEcCtD
Leucovorin—Urticaria—Epirubicin—uterine cancer	0.000215	0.00118	CcSEcCtD
Leucovorin—Constipation—Doxorubicin—uterine cancer	0.000214	0.00117	CcSEcCtD
Leucovorin—Abdominal pain—Epirubicin—uterine cancer	0.000214	0.00117	CcSEcCtD
Leucovorin—Body temperature increased—Epirubicin—uterine cancer	0.000214	0.00117	CcSEcCtD
Leucovorin—Feeling abnormal—Doxorubicin—uterine cancer	0.000207	0.00113	CcSEcCtD
Leucovorin—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000205	0.00112	CcSEcCtD
Leucovorin—TYMS—Mitotic G1-G1/S phases—CDKN1B—uterine cancer	0.000204	0.0037	CbGpPWpGaD
Leucovorin—ABCC4—Ectoderm Differentiation—CCL2—uterine cancer	0.000202	0.00367	CbGpPWpGaD
Leucovorin—ABCC2—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000201	0.00366	CbGpPWpGaD
Leucovorin—ABCC4—Platelet degranulation—VEGFA—uterine cancer	0.0002	0.00364	CbGpPWpGaD
Leucovorin—Hypersensitivity—Epirubicin—uterine cancer	0.0002	0.00109	CcSEcCtD
Leucovorin—Urticaria—Doxorubicin—uterine cancer	0.000199	0.00109	CcSEcCtD
Leucovorin—TYMS—Metabolism—SRD5A2—uterine cancer	0.000199	0.00361	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—NDUFB11—uterine cancer	0.000199	0.00361	CbGpPWpGaD
Leucovorin—Abdominal pain—Doxorubicin—uterine cancer	0.000198	0.00108	CcSEcCtD
Leucovorin—Body temperature increased—Doxorubicin—uterine cancer	0.000198	0.00108	CcSEcCtD
Leucovorin—TYMS—Cell Cycle, Mitotic—YWHAE—uterine cancer	0.000196	0.00357	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	0.000196	0.00356	CbGpPWpGaD
Leucovorin—Asthenia—Epirubicin—uterine cancer	0.000194	0.00106	CcSEcCtD
Leucovorin—TYMS—Cell Cycle—MLH1—uterine cancer	0.000194	0.00353	CbGpPWpGaD
Leucovorin—Pruritus—Epirubicin—uterine cancer	0.000192	0.00105	CcSEcCtD
Leucovorin—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—uterine cancer	0.000191	0.00347	CbGpPWpGaD
Leucovorin—Diarrhoea—Epirubicin—uterine cancer	0.000185	0.00101	CcSEcCtD
Leucovorin—Hypersensitivity—Doxorubicin—uterine cancer	0.000185	0.00101	CcSEcCtD
Leucovorin—TYMS—Retinoblastoma (RB) in Cancer—TP53—uterine cancer	0.000182	0.00331	CbGpPWpGaD
Leucovorin—Asthenia—Doxorubicin—uterine cancer	0.00018	0.000985	CcSEcCtD
Leucovorin—Dizziness—Epirubicin—uterine cancer	0.000179	0.000981	CcSEcCtD
Leucovorin—Pruritus—Doxorubicin—uterine cancer	0.000177	0.000971	CcSEcCtD
Leucovorin—TYMS—Cell Cycle—YWHAE—uterine cancer	0.000176	0.00319	CbGpPWpGaD
Leucovorin—Vomiting—Epirubicin—uterine cancer	0.000172	0.000943	CcSEcCtD
Leucovorin—Diarrhoea—Doxorubicin—uterine cancer	0.000172	0.000939	CcSEcCtD
Leucovorin—Rash—Epirubicin—uterine cancer	0.000171	0.000935	CcSEcCtD
Leucovorin—Dermatitis—Epirubicin—uterine cancer	0.000171	0.000934	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	0.000167	0.00303	CbGpPWpGaD
Leucovorin—Dizziness—Doxorubicin—uterine cancer	0.000166	0.000907	CcSEcCtD
Leucovorin—ABCC3—Metabolism—SRD5A2—uterine cancer	0.000164	0.00299	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—NDUFB11—uterine cancer	0.000164	0.00299	CbGpPWpGaD
Leucovorin—Nausea—Epirubicin—uterine cancer	0.000161	0.000881	CcSEcCtD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	0.00016	0.0029	CbGpPWpGaD
Leucovorin—Vomiting—Doxorubicin—uterine cancer	0.000159	0.000873	CcSEcCtD
Leucovorin—Rash—Doxorubicin—uterine cancer	0.000158	0.000865	CcSEcCtD
Leucovorin—Dermatitis—Doxorubicin—uterine cancer	0.000158	0.000864	CcSEcCtD
Leucovorin—ABCC4—Hemostasis—IRF1—uterine cancer	0.000155	0.00282	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	0.000154	0.0028	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	0.000151	0.00274	CbGpPWpGaD
Leucovorin—Nausea—Doxorubicin—uterine cancer	0.000149	0.000815	CcSEcCtD
Leucovorin—TYMS—Cell Cycle, Mitotic—CDKN2B—uterine cancer	0.000147	0.00268	CbGpPWpGaD
Leucovorin—ABCC4—Ectoderm Differentiation—CTNNB1—uterine cancer	0.000147	0.00267	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	0.000146	0.00265	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—STAR—uterine cancer	0.000144	0.00261	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—AKR1B1—uterine cancer	0.000144	0.00261	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	0.000142	0.00258	CbGpPWpGaD
Leucovorin—TYMS—Circadian rythm related genes—PTEN—uterine cancer	0.000136	0.00248	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	0.000135	0.00246	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—CDKN2B—uterine cancer	0.000132	0.0024	CbGpPWpGaD
Leucovorin—TYMS—Circadian rythm related genes—EP300—uterine cancer	0.00013	0.00236	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	0.000128	0.00233	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle, Mitotic—BIRC5—uterine cancer	0.000127	0.00231	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—AKR1B1—uterine cancer	0.000119	0.00216	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—STAR—uterine cancer	0.000119	0.00216	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	0.000117	0.00214	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—BIRC5—uterine cancer	0.000114	0.00207	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—POLD1—uterine cancer	0.000113	0.00205	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	0.000109	0.00198	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—AKR1C1—uterine cancer	0.000105	0.00192	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	0.0001	0.00182	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	9.7e-05	0.00176	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—RRM2—uterine cancer	9.39e-05	0.00171	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—POLD1—uterine cancer	9.33e-05	0.0017	CbGpPWpGaD
Leucovorin—TYMS—Circadian rythm related genes—TP53—uterine cancer	9.31e-05	0.00169	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—DCN—uterine cancer	9.12e-05	0.00166	CbGpPWpGaD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—VEGFA—uterine cancer	8.89e-05	0.00162	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—AKR1C1—uterine cancer	8.72e-05	0.00159	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—CYP11A1—uterine cancer	8.59e-05	0.00156	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle, Mitotic—CDKN2A—uterine cancer	8.43e-05	0.00153	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	8.19e-05	0.00149	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—AKR1C3—uterine cancer	8.11e-05	0.00147	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—RRM2—uterine cancer	7.77e-05	0.00141	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—DCN—uterine cancer	7.55e-05	0.00137	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—CDKN2A—uterine cancer	7.54e-05	0.00137	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle, Mitotic—CDKN1B—uterine cancer	7.47e-05	0.00136	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—CYP11A1—uterine cancer	7.11e-05	0.00129	CbGpPWpGaD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—uterine cancer	6.94e-05	0.00126	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—AKR1C3—uterine cancer	6.72e-05	0.00122	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—CDKN1B—uterine cancer	6.68e-05	0.00121	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle, Mitotic—EP300—uterine cancer	6.56e-05	0.00119	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—STK11—uterine cancer	6.32e-05	0.00115	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—CYP19A1—uterine cancer	6.32e-05	0.00115	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—EP300—uterine cancer	5.87e-05	0.00107	CbGpPWpGaD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—AKT1—uterine cancer	5.67e-05	0.00103	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—STK11—uterine cancer	5.23e-05	0.000951	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—CYP19A1—uterine cancer	5.23e-05	0.000951	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	4.91e-05	0.000893	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—EP300—uterine cancer	4.84e-05	0.000879	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—MTHFR—uterine cancer	4.75e-05	0.000863	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—EP300—uterine cancer	4.68e-05	0.000851	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—VEGFA—uterine cancer	4.58e-05	0.000833	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—NRAS—uterine cancer	4.52e-05	0.000822	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—TP53—uterine cancer	4.2e-05	0.000763	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—MTHFR—uterine cancer	3.93e-05	0.000715	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—KRAS—uterine cancer	3.89e-05	0.000708	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—PIK3CA—uterine cancer	3.58e-05	0.00065	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.46e-05	0.00063	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—TP53—uterine cancer	3.46e-05	0.000629	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—HRAS—uterine cancer	3.31e-05	0.000602	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—AKT1—uterine cancer	2.92e-05	0.000531	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—PTEN—uterine cancer	2.64e-05	0.00048	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—EP300—uterine cancer	2.52e-05	0.000458	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—PTEN—uterine cancer	2.19e-05	0.000398	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—EP300—uterine cancer	2.09e-05	0.000379	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—PIK3CA—uterine cancer	1.86e-05	0.000339	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—PIK3CA—uterine cancer	1.54e-05	0.00028	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—AKT1—uterine cancer	1.52e-05	0.000277	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—AKT1—uterine cancer	1.26e-05	0.000229	CbGpPWpGaD
